Fact CheckerSign in

NCT07068919Not yet recruiting

Prospective Evaluation of Probabilistic Predictions of Epileptic Seizure Risk Using the EPIDAY Tool

Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Studies suggest the existence of a pre-critical state preceding the onset of an epileptic seizure. Identifying these states from self-reported prodromal symptoms, combined with machine learning algorithms, could help anticipate seizures.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
7 Jul 2025
Start date
1 Oct 2025
Primary completion date
31 Jan 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
Epilepsy
NCT number
NCT07068919

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Oct 2025 to the primary completion date, 31 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Suspicion or diagnosis of other types of associated malaise: functional dissociative seizures, syncope or other malaise of non-neurological origin
  • Assessment of seizure frequency deemed unreliable by the investigator (eg. due to cognitive impairment)
  • Inability to describe seizures accurately
  • Presence of more than 15 days with seizures per month

Other

  • Participation in other interventional research or exclusion period not expired
  • Pregnant or breastfeeding woman
  • Patient under guardianship, curatorship, deprived of liberty

Who the study is looking for

  • Age between 18 and 65
  • Focal epilepsy diagnosed for at least 18 months
  • Brain imaging as part of the etiological work-up for epilepsy showing no progressive cause
  • EEG compatible with the diagnosis of epilepsy within the last 10 years
  • At least 2 non-contiguous days of epileptic seizures per month, according to the patient
  • Ability of the patient to understand and use a mobile application on the personal smartphone
  • Free, informed and signed consent
  • Affiliation with a social security scheme (excluding AME)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Pitié-Salpêtrière - AP-HP
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.